Regulation of proteolytic activity of complement factor I by pH: C3b/C4b receptor (CR1) and membrane cofactor protein (MCP) have different pH optima for factor I-mediated cleavage of C3b.

Regulation of proteolytic activity of complement factor I by pH: C3b/C4b receptor (CR1) and membrane cofactor protein (MCP) have different pH optima for factor I-mediated cleavage of C3b. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Regulation of proteolytic activity of complement factor I by pH: C3b/C4b receptor (CR1) and membrane cofactor protein (MCP) have different pH optima for factor I-mediated cleavage of C3b. Abstract Text:

T Seya,M Okada,H Nishino,J P Atkinson,

C3b/C4b receptor (CR1) and membrane cofactor protein (MCP) are integral membrane glycoproteins with factor I-dependent cofactor activity. They bind to C3b, allowing factor I to cleave C3b at two sites (first and second cleavage), which results in the generation of C3bi, a hemolytically inactive form which is a ligand for complement receptor type three (CR3). C3bi is further degraded by factor I and CR1 (third cleavage) to C3dg (a ligand for complement receptor type two, CR2) and C3c. Using two different substrates, fluid-phase C3b and cell-bound C3b, the cleavage of C3b by MCP and factor I was compared to that by CR1 and factor I under various conditions. The optimal pH for the first and second cleavage of either substrate was 6.0 for MCP and 7.5 for CR1. The third cleavage was mediated only by CR1 and factor I, the optimal pH being 8.0. Low ionic conditions enhanced the C3b binding and cofactor activity of both CR1 and MCP. The efficiency of binding C3b to CR1 or MCP was maximal at pH 6.2. The isoelectric point (pI) of MCP was acidic (approximately 4.0), while that of CR1 was 6.8. Therefore, compared to CR1, MCP possesses distinct functional profiles relative to C3b-binding and factor I-cofactor activity.

Regulation of proteolytic activity of complement factor I by pH: C3b/C4b receptor (CR1) and membrane cofactor protein (MCP) have different pH optima for factor I-mediated cleavage of C3b. Publishing Authors By Initials

T Seya,M Okada,H Nishino,JP Atkinson,

For similar enzymes and coenzymes: enzymes: hydrolases: peptide hydrolases: endopeptidases: serine endopeptidases research abstracts see: enzymes and coenzymes: enzymes: hydrolases: peptide hydrolases: endopeptidases: serine endopeptidases research

PUBMED ID PMID:

MEDLINE DATE:

Regulation of proteolytic activity of complement factor I by pH: C3b/C4b receptor (CR1) and membrane cofactor protein (MCP) have different pH optima for factor I-mediated cleavage of C3b. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Journal of biochemistry

VOLUME: 107

Page Numbers: 310-5

Journal Abbreviation: J. Biochem.

ISSN: 0021-924X

DAY: 19

MONTH: Feb

YEAR: 1990

Regulation of proteolytic activity of complement factor I by pH: C3b/C4b receptor (CR1) and membrane cofactor protein (MCP) have different pH optima for factor I-mediated cleavage of C3b. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 376600

Regulation of proteolytic activity of complement factor I by pH: C3b/C4b receptor (CR1) and membrane cofactor protein (MCP) have different pH optima for factor I-mediated cleavage of C3b. Keywords Mesh Terms:

KEYWORDS: Serine Endopeptidases

MESH TERMS: metabolism

Chemical & Substance for Abstract: Regulation of proteolytic activity of complement factor I by pH: C3b/C4b receptor (CR1) and membrane cofactor protein (MCP) have different pH optima for factor I-mediated cleavage of C3b. Information

Substance Name: Complement Factor I

Registry Number: EC 3.4.21.45

Grant and Affiliation Information for Regulation of proteolytic activity of complement factor I by pH: C3b/C4b receptor (CR1) and membrane cofactor protein (MCP) have different pH optima for factor I-mediated cleavage of C3b.

AFFILIATION: Department of Immunology, Center for Adult Diseases, Osaka.

Country: JAPAN

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Biochem

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Regulation of proteolytic activity of complement factor I by pH: C3b/C4b receptor CR1 and membrane cofactor protein MCP have different pH optima for factor I-mediated cleavage of C3b Related Publications

• Acute changes in cardiovascular function during the onset period of daytime sleep: comparison to lying awake and standing.
• Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndrome.
• Comparison of combinations of drugs for treatment of obesity: body weight and echocardiographic status.
• Computer automated movement detection for the analysis of behavior.
• Conformation and lipid binding of a C-terminal (198-243) peptide of human apolipoprotein A-I.
• Cutting edge: treatment of complement regulatory protein deficiency by retroviral in vivo gene therapy.
• Developing a Questionnaire to Measure Perceived Attributes of eHealth Innovations.
• Development of brain mechanisms for visual global processing and object segmentation.
• Drug-induced epigenetic changes produce drug tolerance.
• Epidemiology of hip fractures in Belgrade, Serbia Montenegro, 1990-2000.
• Grounded theory research: literature reviewing and reflexivity.
• Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome.
• International journal of sports medicine: progress and innovation in cycling science 2001-2007.
• Introduction and Overview: 470: 9:00 AM-9:05 AM.
• Is hepatitis C infection associated with increased risk of depression in persons with methamphetamine dependence?
• Modeling how CD46 deficiency predisposes to atypical hemolytic uremic syndrome.
• Modeling the causal relationships between symptoms associated with restless legs syndrome and the patient-reported impact of RLS.
• Mutations in CD46, a complement regulatory protein, predispose to atypical HUS.
• Outcomes of primary thyroid non-Hodgkin's lymphoma: a series of nine consecutive cases.
• Overview of emergency medical services in North Carolina.
• Physical Activity and Shiftwork: 473: 9:55 AM-10:20 AM.
• Post-Exercise Cardiac TVoponin T: A Meta-Analysis: 1745: Board #33 May 31 9:00 AM 10:30 AM.
• Reversible reproductive control in harbour seals (Phoca vitulina) with a gonadotropin-releasing hormone agonist.
• Risk reduction strategies in ischaemic stroke : the role of antiplatelet therapy.
• Semantic interference and associative facilitation from words presented in rapid serial visual presentation.
• Systemic humoral autoimmunity but joint-specific inflammation: the syndrome of rheumatoid arthritis.
• Testis-specific expression of the beta2 tubulin promoter of Aedes aegypti and its application as a genetic sex-separation marker.
• The effects of single and repeated bouts of soccer-specific exercise on salivary IgA.
• The nutritional effects of endoscopic intubation for carcinoma of the oesophagus or cardia.
• Using two-component systems and other bacterial regulatory factors for the fabrication of synthetic genetic devices.